Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

This public procurement record has 2 releases in its history.

Award

15 Aug 2019 at 01:00

OJEU - F3 - Contract Award Notice
Tender

15 Mar 2019 at 00:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The procurement process is led by The Common Services Agency, also known as NHS National Services Scotland (NSS), located at Gyle Square, Edinburgh. The tender, titled "Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines," falls under the health industry category, with an estimated contract value of approximately £33.36 million and spans a duration of 23 months, with a possible 24-month extension. The procurement method utilised is an open procedure, and the tender period concluded on 18 April 2019, marking the transition to the award stage.

This framework agreement creates substantial opportunities for suppliers in the pharmaceutical sector, particularly those offering generic medicines related to gastroenterology, endocrinology, nutrition, and blood health. Businesses with relevant capabilities in producing or distributing such pharmaceuticals will find themselves well-positioned to compete. With a multi-supplier framework structure, successful bidders can anticipate secured contracts across various product lines, fostering long-term partnerships with NHS Scotland.

How relevant is this notice?

Notice Information

Notice Title

Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines

Notice Description

This Framework Agreement is for the supply of a range of Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines to NHS Scotland. The Goods have been separated into ten (10) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Information

Lot 1 Desferrioxamine Injections

Supply of Desferrioxamine Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 2 Dexamethasone Injections

The Supply of Dexamethasone Injections to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 3 Macrogol Oral Powder & Solutions

The Supply of Macrogol Oral Powder & Solutions to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 4 Mesalazine

The Supply of Mesalazine to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 5 Magnesium Sulfate

The supply of Magnesium sulfate to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Lot 6 Calcium Carbonate Tablets

The Supply of Calcium Carbonate Tablets to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Lot 7 Budesonide

The supply of Budesonide to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 8 Vitamin with minerals and trace elements

The supply of Vitamin with minerals and trace elements to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 9 - Pancreatin

The supply of Pancreatin to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Lot 10 All Other Presentations

Supply of all other products/presentations within this tender to NHS Scotland. Each product line will be treated as an individual lot and awarded to a single supplier Participant. Full details of Goods and volumes can be found within the ITT documents.

Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000576809
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG363475
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£33,357,901 £10M-£100M
Lots Value
£33,357,903 £10M-£100M
Awards Value
Not specified
Contracts Value
£24,562,617 £10M-£100M

Notice Dates

Publication Date
15 Aug 20197 years ago
Submission Deadline
18 Apr 2019Expired
Future Notice Date
Not specified
Award Date
16 Jul 20197 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Unsuccessful
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
39
Supplier Names

Accord UK Ltd

Allergan Ltd

Aventis Pharma Ltd Trading As Sanofi

Bowmed Ibisqus Limited

Brown and Burk

Chiesi Limited

Creo Pharma Limited

Crescent Pharma Limited

Dr Falk Pharma UK Ltd

Dr Reddy's Laboratories (UK) Ltd

Ennogen Healthcare Ltd

Ferring Pharmaceuticals Limited

Focus Pharmaceuticals Ltd

GSK UK Limited

Galen Ltd

Glenmark Pharmaceuticals Europe Ltd

Intrapharm Laboratories Ltd

Kent Pharmaceuticals Ltd

Kyowa Kirin

MYLAN UK HEALTHCARE LIMITED

Martindale Pharma

Mercury Pharmaceuticals Limited

Morningside Pharmaceuticals Limited

Norgine Pharmaceuticals Limited

Panpharma UK Ltd

Pfizer Ltd

RB UK Commercial Ltd

Ranbaxy (UK) Ltd

Rosemont Pharmaceuticals Ltd

Sandoz Ltd

Selective Supplies Ltd

Shire Pharmaceuticals Limited

Syri Limited T/A Thame Laboratories

Teva UK Limited

Thornton & Ross

Tillotts Pharma Uk ltd

Typharm Ltd

Wockhardt UK Limited

hameln pharmaceuticals ltd

Further Information

Notice Documents

  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR348631
    Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines - This Framework Agreement is for the supply of a range of Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines to NHS Scotland. The Goods have been separated into ten (10) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG363475
    Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines - This Framework Agreement is for the supply of a range of Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines to NHS Scotland. The Goods have been separated into ten (10) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...